{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:52:55Z","timestamp":1789782775993,"version":"4.0.1"},"reference-count":193,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2013,12,29]],"date-time":"2013-12-29T00:00:00Z","timestamp":1388275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s11010-013-1951-9","type":"journal-article","created":{"date-parts":[[2013,12,28]],"date-time":"2013-12-28T08:48:22Z","timestamp":1388220502000},"page":"277-291","source":"Crossref","is-referenced-by-count":18,"title":["A mitochondrial basis for Huntington\u2019s disease: therapeutic prospects"],"prefix":"10.1007","volume":"389","author":[{"given":"J.","family":"Chakraborty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Rajamma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. P.","family":"Mohanakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,29]]},"reference":[{"key":"1951_CR1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s disease collaborative research group","year":"1993","unstructured":"The Huntington\u2019s disease collaborative research group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"1951_CR2","first-page":"16","volume":"59","author":"DC Rubinsztein","year":"1996","unstructured":"Rubinsztein DC, Leggo J, Coles R et al (1996) Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats. Am J Hum Genet 59:16\u201322","journal-title":"Am J Hum Genet"},{"key":"1951_CR3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/2.9.1475","volume":"2","author":"A N\u00f8rrem\u00f8lle","year":"1993","unstructured":"N\u00f8rrem\u00f8lle A, Riess O, Epplen JT, Fenger K, Hasholt L, S\u00f8rensen SA (1993) Trinucleotide repeat elongation in the Huntingtin gene in Huntington disease patients from 71 Danish families. Hum Mol Genet 2:1475\u20131476","journal-title":"Hum Mol Genet"},{"key":"1951_CR4","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1093\/hmg\/2.12.2063","volume":"2","author":"C Z\u00fchlke","year":"1993","unstructured":"Z\u00fchlke C, Riess O, Bockel B, Lange H, Thies U (1993) Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene. Hum Mol Genet 2:2063\u20132067","journal-title":"Hum Mol Genet"},{"key":"1951_CR5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/0896-6273(95)90345-3","volume":"14","author":"AH Sharp","year":"1995","unstructured":"Sharp AH, Love SJ, Schilling G et al (1995) Widespread expression of Huntington\u2019s disease gene (IT15) protein product. Neuron 14:1065\u20131074","journal-title":"Neuron"},{"key":"1951_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR et al (1995) Targeted disruption of the Huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811\u2013823","journal-title":"Cell"},{"key":"1951_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0896-6273(00)80764-3","volume":"23","author":"JG Hodgson","year":"1999","unstructured":"Hodgson JG, Agopyan N, Gutekunst CA et al (1999) A YAC mouse model for Huntington\u2019s disease with full-length mutant Huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron 23:181\u2013192","journal-title":"Neuron"},{"key":"1951_CR8","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD et al (2004) Mutant Huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195\u20138209","journal-title":"Mol Cell Biol"},{"key":"1951_CR9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19:233\u2013238","journal-title":"Trends Genet"},{"key":"1951_CR10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.expneurol.2012.11.025","volume":"241","author":"JE Borgonovo","year":"2013","unstructured":"Borgonovo JE, Troncoso M, Lucas JJ, Sosa MA (2013) Mutant Huntingtin affects endocytosis in striatal cells by altering the binding of AP-2 to membranes. Exp Neurol 241:75\u201383","journal-title":"Exp Neurol"},{"key":"1951_CR11","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1093\/hmg\/ddl434","volume":"15","author":"E Trushina","year":"2006","unstructured":"Trushina E, Singh RD, Dyer RB, Cao S, Shah VH, Parton RG, Pagano RE, McMurray CT (2006) Mutant Huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet 15:3578\u20133591","journal-title":"Hum Mol Genet"},{"key":"1951_CR12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4161\/auto.5201","volume":"4","author":"RS Atwal","year":"2008","unstructured":"Atwal RS, Truant R (2008) A stress sensitive ER membrane-association domain in Huntingtin protein defines a potential role for Huntingtin in the regulation of autophagy. Autophagy 4:91\u201393","journal-title":"Autophagy"},{"key":"1951_CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/hmg\/ddl440","volume":"16","author":"E Rockabrand","year":"2007","unstructured":"Rockabrand E, Slepko N, Pantalone A et al (2007) The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet 16:61\u201377","journal-title":"Hum Mol Genet"},{"key":"1951_CR14","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"1951_CR15","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2003.11.021","volume":"15","author":"M Napolitano","year":"2004","unstructured":"Napolitano M, Centonze D, Gubellini P, Rossi S, Spiezia S, Bernardi G, Gulino A, Calabresi P (2004) Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington\u2019s disease. Neurobiol Dis 15:407\u2013414","journal-title":"Neurobiol Dis"},{"key":"1951_CR16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuint.2009.04.013","volume":"55","author":"M Pandey","year":"2009","unstructured":"Pandey M, Borah A, Varghese M, Barman PK, Mohanakumar KP, Usha R (2009) Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington\u2019s disease in rats. Neurochem Int 55:431\u2013437","journal-title":"Neurochem Int"},{"key":"1951_CR17","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1046\/j.0953-816x.2001.01767.x","volume":"14","author":"O Hansson","year":"2001","unstructured":"Hansson O, Guatteo E, Mercuri NB, Bernardi G, Li XJ, Castilho RF, Brundin P (2001) Resistance to NMDA toxicity correlates with appearance of nuclear inclusions, behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the Huntington gene. Eur J Neurosci 14:1492\u20131504","journal-title":"Eur J Neurosci"},{"key":"1951_CR18","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.1073\/pnas.96.15.8727","volume":"96","author":"O Hansson","year":"1999","unstructured":"Hansson O, Peters\u00e9n A, Leist M, Nicotera P, Castilho RF, Brundin P (1999) Transgenic mice expressing a Huntington\u2019s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc Natl Acad Sci USA 96:8727\u20138732","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR19","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1471-4159.2004.02565.x","volume":"90","author":"EN Maciel","year":"2004","unstructured":"Maciel EN, Kowaltowski AJ, Schwalm FD, Rodrigues JM, Souza DO, Vercesi AE, Wajner M, Castilho RF (2004) Mitochondrial permeability transition in neuronal damage promoted by Ca2+ and respiratory chain complex II inhibition. J Neurochem 90:1025\u20131035","journal-title":"J Neurochem"},{"key":"1951_CR20","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0006-8993(00)01948-X","volume":"858","author":"MA Fontaine La","year":"2000","unstructured":"La Fontaine MA, Geddes JW, Banks A, Butterfield DA (2000) 3-Nitropropionic acid-induced in vivo protein oxidation in striatal and cortical synaptosomes: insights into Huntington\u2019s disease. Brain Res 858:356\u2013362","journal-title":"Brain Res"},{"key":"1951_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MWJ, Xuereb J, Taanman JW, Cooper JM, Schapira AHV (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"1951_CR22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","volume":"359","author":"CM Chen","year":"2007","unstructured":"Chen CM, Wu YR, Cheng ML, Liu JL, Lee YM, Lee PW, Soong BW, Chiu DTY (2007) Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington\u2019s disease patients. Biochem Biophys Res Com 359:335\u2013340","journal-title":"Biochem Biophys Res Com"},{"key":"1951_CR23","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s11064-006-9110-2","volume":"31","author":"P Hoyo del","year":"2006","unstructured":"del Hoyo P, Redondo AG, de Bustos F et al (2006) Oxidative stress in skin fibroblasts cultures of patients with Huntington\u2019s disease. Neurochem Res 31:1103\u20131109","journal-title":"Neurochem Res"},{"key":"1951_CR24","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.1831768100","volume":"100","author":"M Cyr","year":"2003","unstructured":"Cyr M, Beaulieu JM, Laakso A et al (2003) Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci USA 100:11035\u201311040","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR25","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/hmg\/ddn033","volume":"17","author":"A Benchoua","year":"2008","unstructured":"Benchoua A, Trioulier Y, Diguet E et al (2008) Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant Huntingtin through the regulation of mitochondrial complex II. Hum Mol Genet 17:1446\u20131456","journal-title":"Hum Mol Genet"},{"key":"1951_CR26","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181\u20134192","journal-title":"J Neurosci"},{"key":"1951_CR27","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","volume":"104","author":"M Pandey","year":"2008","unstructured":"Pandey M, Varghese M, Sindhu KM, Sreetama S, Navneet AK, Mohanakumar KP, Usha R (2008) Mitochondrial NAD+-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. J Neurochem 104:420\u2013434","journal-title":"J Neurochem"},{"key":"1951_CR28","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1073\/pnas.0812083106","volume":"106","author":"Y Nekooki-Machida","year":"2009","unstructured":"Nekooki-Machida Y, Kurosawa M, Nukina N, Ito K, Oda T, Tanaka M (2009) Distinct conformations of in vitro and in vivo amyloids of Huntingtin-exon1 show different cytotoxicity. Proc Natl Acad Sci USA 106:9679\u20139684","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/7.5.783","volume":"7","author":"JK Cooper","year":"1998","unstructured":"Cooper JK, Schilling G, Peters MF et al (1998) Truncated N-terminal fragments of Huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 7:783\u2013790","journal-title":"Hum Mol Genet"},{"key":"1951_CR30","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","volume":"11","author":"W Yang","year":"2002","unstructured":"Yang W, Dunlap JR, Andrews RB, Wetzel R (2002) Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum Mol Genet 11:2905\u20132917","journal-title":"Hum Mol Genet"},{"key":"1951_CR31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant Huntingtin and the risk of neuronal death. Nature 431:805\u2013810","journal-title":"Nature"},{"key":"1951_CR32","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N (1997) Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:1990\u20131993","journal-title":"Science"},{"key":"1951_CR33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A (2011) Mutant Huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377\u2013382","journal-title":"Nat Med"},{"key":"1951_CR34","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant Huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455","journal-title":"Hum Mol Genet"},{"key":"1951_CR35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ana.410410514","volume":"41","author":"SE Browne","year":"1997","unstructured":"Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit MM, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington\u2019s disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646\u2013653","journal-title":"Ann Neurol"},{"key":"1951_CR36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant Huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum Mol Genet 21:406\u2013420","journal-title":"Hum Mol Genet"},{"key":"1951_CR37","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"1951_CR38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.410430321","volume":"43","author":"J Arenas","year":"1998","unstructured":"Arenas J, Campos Y, Ribacoba R, Mart\u00edn MA, Rubio JC, Ablanedo P, Cabello A (1998) Complex I defect in muscle from patients with Huntington\u2019s disease. Ann Neurol 43:397\u2013400","journal-title":"Ann Neurol"},{"key":"1951_CR39","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D et al (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin. Mol Biol Cell 17:1652\u20131663","journal-title":"Mol Biol Cell"},{"key":"1951_CR40","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92:7105\u20137109","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR41","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/j.1471-4159.2005.03515.x","volume":"95","author":"E Brouillet","year":"2005","unstructured":"Brouillet E, Jacquard C, Bizat N, Blum D (2005) 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington\u2019s disease. J Neurochem 95:1521\u20131540","journal-title":"J Neurochem"},{"key":"1951_CR42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1471-4159.1993.tb05859.x","volume":"60","author":"E Brouillet","year":"1993","unstructured":"Brouillet E, Jenkins BG, Hyman BT et al (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J Neurochem 60:356\u2013359","journal-title":"J Neurochem"},{"key":"1951_CR43","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","volume":"18","author":"AC Ludolph","year":"1991","unstructured":"Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492\u2013498","journal-title":"Can J Neurol Sci"},{"key":"1951_CR44","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1523\/JNEUROSCI.16-09-03019.1996","volume":"16","author":"S Palfi","year":"1996","unstructured":"Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, Guyot MC, Peschanski M, Hantraye P (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington\u2019s disease. J Neurosci 16:3019\u20133025","journal-title":"J Neurosci"},{"key":"1951_CR45","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/hmg\/10.10.1049","volume":"10","author":"NR Jana","year":"2001","unstructured":"Jana NR, Zemskov EA, Wang Gh, Nukina N (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal Huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome\u00a0c release. Hum Mol Genet 10:1049\u20131059","journal-title":"Hum Mol Genet"},{"key":"1951_CR46","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/hmg\/ddm023","volume":"16","author":"H Fukui","year":"2007","unstructured":"Fukui H, Moraes CT (2007) Extended polyglutamine repeats trigger a feedback loop involving the mitochondrial complex III, the proteasome and Huntingtin aggregates. Hum Mol Genet 16:783\u2013797","journal-title":"Hum Mol Genet"},{"key":"1951_CR47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0304-3940(99)00578-9","volume":"272","author":"MC Polidori","year":"1999","unstructured":"Polidori MC, Mecocci P, Browne SE, Senin U, Beal MF (1999) Oxidative damage to mitochondrial DNA in Huntington\u2019s disease parietal cortex. Neurosci Lett 272:53\u201356","journal-title":"Neurosci Lett"},{"key":"1951_CR48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","volume":"18","author":"H Braak","year":"1992","unstructured":"Braak H, Braak E (1992) Allocortical involvement in Huntington\u2019s disease. Neuropathol Appl Neurobiol 18:539\u2013547","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1951_CR49","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1172\/JCI10268","volume":"106","author":"JJ Lehman","year":"2000","unstructured":"Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP (2000) Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest 106:847\u2013856","journal-title":"J Clin Invest"},{"key":"1951_CR50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98:115\u2013124","journal-title":"Cell"},{"key":"1951_CR51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369","journal-title":"Cell"},{"key":"1951_CR52","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","volume":"18","author":"RK Chaturvedi","year":"2009","unstructured":"Chaturvedi RK, Adhihetty P, Shukla S et al (2009) Impaired PGC-1\u03b1 function in muscle in Huntington\u2019s disease. Hum Mol Genet 18:3048\u20133065","journal-title":"Hum Mol Genet"},{"key":"1951_CR53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362","journal-title":"Cell Metab"},{"key":"1951_CR54","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1523\/JNEUROSCI.3455-07.2007","volume":"27","author":"HB Fernandes","year":"2007","unstructured":"Fernandes HB, Baimbridge KG, Church J, Hayden MR, Raymond LA (2007) Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington\u2019s disease. J Neurosci 27:13614\u201313623","journal-title":"J Neurosci"},{"key":"1951_CR55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11010-005-3454-9","volume":"269","author":"AV Panov","year":"2005","unstructured":"Panov AV, Lund S, Greenamyre JT (2005) Ca2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington\u2019s disease individuals. Mol Cell Biochem 269:143\u2013152","journal-title":"Mol Cell Biochem"},{"key":"1951_CR56","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1046\/j.1471-4159.2003.02250.x","volume":"88","author":"TR Rosenstock","year":"2004","unstructured":"Rosenstock TR, Carvalho AC, Jurkiewicz A, Frussa-Filho R, Smaili SS (2004) Mitochondrial calcium, oxidative stress and apoptosis in a neurodegenerative disease model induced by 3-nitropropionic acid. J Neurochem 88:1220\u20131228","journal-title":"J Neurochem"},{"key":"1951_CR57","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1091\/mbc.12.8.2245","volume":"12","author":"E Smirnova","year":"2001","unstructured":"Smirnova E, Griparic L, Shurland DL, van der Bliek AM (2001) Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 12:2245\u20132256","journal-title":"Mol Biol Cell"},{"key":"1951_CR58","doi-asserted-by":"crossref","first-page":"15803","DOI":"10.1073\/pnas.0808249105","volume":"105","author":"GM Cereghetti","year":"2008","unstructured":"Cereghetti GM, Stangherlin A, Martins de Brito O (2008) Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci USA 105:15803\u201315808","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR59","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/sj.embor.7401062","volume":"8","author":"JT Cribbs","year":"2007","unstructured":"Cribbs JT, Strack S (2007) Reversible phosphorylation of Drp1 by cyclic AMP-dependent protein kinase and calcineurin regulates mitochondrial fission and cell death. EMBO Rep 8:939\u2013944","journal-title":"EMBO Rep"},{"key":"1951_CR60","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.cub.2004.02.004","volume":"14","author":"Z Harder","year":"2004","unstructured":"Harder Z, Zunino R, McBride H (2004) Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol 14:340\u2013345","journal-title":"Curr Biol"},{"key":"1951_CR61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1083\/jcb.200611064","volume":"178","author":"M Karbowski","year":"2007","unstructured":"Karbowski M, Neutzner A, Youle RJ (2007) The mitochondrial E3 ubiquitin ligase MARCH5 is required for Drp1 dependent mitochondrial division. J Cell Biol 178:71\u201384","journal-title":"J Cell Biol"},{"key":"1951_CR62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1242\/jcs.061481","volume":"123","author":"YY Park","year":"2010","unstructured":"Park YY, Lee S, Karbowski M, Neutzner A, Youle RJ, Cho H (2010) Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci 123:619\u2013626","journal-title":"J Cell Sci"},{"key":"1951_CR63","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1074\/jbc.M607279200","volume":"282","author":"N Taguchi","year":"2007","unstructured":"Taguchi N, Ishihara N, Jofuku A, Oka T, Mihara K (2007) Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 282:11521\u201311529","journal-title":"J Biol Chem"},{"key":"1951_CR64","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1242\/jcs.03418","volume":"120","author":"R Zunino","year":"2007","unstructured":"Zunino R, Schauss A, Rippstein P, Andrade-Navarro M, McBride HM (2007) The SUMO protease SENP5 is required to maintain mitochondrial morphology and function. J Cell Sci 120:1178\u20131188","journal-title":"J Cell Sci"},{"key":"1951_CR65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.mito.2010.04.007","volume":"10","author":"T Nakamura","year":"2010","unstructured":"Nakamura T, Cieplak P, Cho DH, Godzik A, Lipton SA (2010) S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration. Mitochondrion 10:573\u2013578","journal-title":"Mitochondrion"},{"key":"1951_CR66","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/hmg\/ddn404","volume":"18","author":"H Wang","year":"2009","unstructured":"Wang H, Lim PJ, Karbowski M, Monteiro MJ (2009) Effects of overexpression of Huntingtin proteins on mitochondrial integrity. Hum Mol Genet 18:737\u2013752","journal-title":"Hum Mol Genet"},{"key":"1951_CR67","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2:490\u2013503","journal-title":"EMBO Mol Med"},{"key":"1951_CR68","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/cdd.2009.22","volume":"16","author":"G Liot","year":"2009","unstructured":"Liot G, Bossy B, Lubitz S, Kushnareva Y, Sejbuk N, Bossy-Wetzel E (2009) Complex II inhibition by 3-NP causes mitochondrial fragmentation and neuronal cell death via an NMDA- and ROS-dependent pathway. Cell Death Differ 16:899\u2013909","journal-title":"Cell Death Differ"},{"key":"1951_CR69","doi-asserted-by":"crossref","unstructured":"Haun F, Nakamura T, Shiu AD, Cho DH, Tsunemi T, Holland EA, La Spada AR, Lipton SA (2013) S-Nitrosylation of dynamin-related protein 1 mediates mutant Huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington\u2019s disease. Antioxid Redox Signal\u00a019:1173\u20131184","DOI":"10.1089\/ars.2012.4928"},{"key":"1951_CR70","doi-asserted-by":"crossref","first-page":"e7874","DOI":"10.1371\/journal.pone.0007874","volume":"4","author":"RM Baqri","year":"2009","unstructured":"Baqri RM, Turner BA, Rheuben MB, Hammond BD, Kaguni LS, Miller KE (2009) Disruption of mitochondrial DNA replication in Drosophila increases mitochondrial fast axonal transport in vivo. PLoS One 4:e7874","journal-title":"PLoS One"},{"key":"1951_CR71","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1242\/jcs.01130","volume":"117","author":"KE Miller","year":"2004","unstructured":"Miller KE, Sheetz MP (2004) Axonal mitochondrial transport and potential are correlated. J Cell Sci 117:2791\u20132804","journal-title":"J Cell Sci"},{"key":"1951_CR72","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1242\/jcs.02745","volume":"118","author":"PJ Hollenbeck","year":"2005","unstructured":"Hollenbeck PJ, Saxton WM (2005) The axonal transport of mitochondria. J Cell Sci 118:5411\u20135419","journal-title":"J Cell Sci"},{"key":"1951_CR73","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1242\/jcs.053850","volume":"125","author":"WM Saxton","year":"2012","unstructured":"Saxton WM, Hollenbeck PJ (2012) The axonal transport of mitochondria. J Cell Sci 125:2095\u20132104","journal-title":"J Cell Sci"},{"key":"1951_CR74","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuron.2005.06.027","volume":"47","author":"X Guo","year":"2005","unstructured":"Guo X, Macleod GT, Wellington A (2005) The GTPase dMiro is required for axonal transport of mitochondria to Drosophila synapses. Neuron 47:379\u2013393","journal-title":"Neuron"},{"key":"1951_CR75","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.febslet.2009.04.015","volume":"583","author":"K Reis","year":"2009","unstructured":"Reis K, Fransson A, Aspenstr\u00f6m P (2009) The Miro GTPases: at the heart of the mitochondrial transport machinery. FEBS Lett 583:1391\u20131398","journal-title":"FEBS Lett"},{"key":"1951_CR76","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.mcn.2008.10.016","volume":"40","author":"AF MacAskill","year":"2009","unstructured":"MacAskill AF, Brickley K, Stephenson FA, Kittler JT (2009) GTPase dependent recruitment of Grif-1 by Miro1 regulates mitochondrial trafficking in hippocampal neurons. Mol Cell Neurosci 40:301\u2013312","journal-title":"Mol Cell Neurosci"},{"key":"1951_CR77","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/ncb1169","volume":"6","author":"Q Su","year":"2004","unstructured":"Su Q, Cai Q, Gerwin C, Smith CL, Sheng ZH (2004) Syntabulin is a microtubule-associated protein implicated in syntaxin transport in neurons. Nat Cell Biol 6:941\u2013953","journal-title":"Nat Cell Biol"},{"key":"1951_CR78","doi-asserted-by":"crossref","first-page":"13019","DOI":"10.1523\/JNEUROSCI.2517-09.2009","volume":"29","author":"H Ma","year":"2009","unstructured":"Ma H, Cai Q, Lu W, Sheng ZH, Mochida S (2009) KIF5B motor adaptor syntabulin maintains synaptic transmission in sympathetic neurons. J Neurosci 29:13019\u201313029","journal-title":"J Neurosci"},{"key":"1951_CR79","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tcb.2009.11.002","volume":"20","author":"AF MacAskill","year":"2010","unstructured":"MacAskill AF, Kittler JT (2010) Control of mitochondrial transport and localization in neurons. Trends Cell Biol 20:102\u2013112","journal-title":"Trends Cell Biol"},{"key":"1951_CR80","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1357-2725(02)00026-2","volume":"34","author":"C Schwarzer","year":"2002","unstructured":"Schwarzer C, Barnikol-Watanabe S, Thinnes FP, Hilschmann N (2002) Voltage-dependent anion-selective channel (VDAC) interacts with the dynein light chain Tctex1 and the heat-shock protein PBP74. Int J Biochem Cell Biol 34:1059\u20131070","journal-title":"Int J Biochem Cell Biol"},{"key":"1951_CR81","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1523\/JNEUROSCI.0095-11.2011","volume":"31","author":"N Ohno","year":"2011","unstructured":"Ohno N, Kidd GJ, Mahad D, Kiryu-Seo S, Avishai A, Komuro H, Trapp BD (2011) Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci 31:7249\u20137258","journal-title":"J Neurosci"},{"key":"1951_CR82","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1471-4159.2006.03788.x","volume":"97","author":"GL Rintoul","year":"2006","unstructured":"Rintoul GL, Bennett VJ, Papaconstandinou NA, Reynolds IJ (2006) Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 97:800\u2013806","journal-title":"J Neurochem"},{"key":"1951_CR83","doi-asserted-by":"crossref","first-page":"7881","DOI":"10.1523\/JNEUROSCI.23-21-07881.2003","volume":"23","author":"GL Rintoul","year":"2003","unstructured":"Rintoul GL, Filiano AJ, Brocard JB, Kress GJ, Reynolds IJ (2003) Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 23:7881\u20137888","journal-title":"J Neurosci"},{"key":"1951_CR84","first-page":"114","volume":"303","author":"M M\u00fcller","year":"2005","unstructured":"M\u00fcller M, Mironov SL, Ivannikov MV, Schmidt J, Richter DW (2005) Mitochondrial organization and motility probed by two-photon microscopy in cultured mouse brainstem neurons. Exp Cell Res 303:114\u2013127","journal-title":"Exp Cell Res"},{"key":"1951_CR85","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1471-4159.2006.03767.x","volume":"97","author":"SA Zanelli","year":"2006","unstructured":"Zanelli SA, Trimmer PA, Solenski NJ (2006) Nitric oxide impairs mitochondrial movement in cortical neurons during hypoxia. J Neurochem 97:724\u2013736","journal-title":"J Neurochem"},{"key":"1951_CR86","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1523\/JNEUROSCI.4551-09.2010","volume":"30","author":"CL Zhang","year":"2010","unstructured":"Zhang CL, Ho PL, Kintner DB, Sun D, Chiu SY (2010) Activity-dependent regulation of mitochondrial motility by calcium and Na\/K-ATPase at nodes of Ranvier of myelinated nerves. J Neurosci 30:3555\u20133566","journal-title":"J Neurosci"},{"key":"1951_CR87","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1523\/JNEUROSCI.6248-09.2010","volume":"30","author":"A Misko","year":"2010","unstructured":"Misko A, Jiang S, Wegorzewska I, Milbrandt J, Baloh RH (2010) Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro\/Milton complex. J Neurosci 30:4232\u20134240","journal-title":"J Neurosci"},{"key":"1951_CR88","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"DT Chang","year":"2006","unstructured":"Chang DT, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant Huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22:388\u2013400","journal-title":"Neurobiol Dis"},{"key":"1951_CR89","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H (2008) N-terminal mutant Huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci 28:2783\u20132792","journal-title":"J Neurosci"},{"key":"1951_CR90","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118:127\u2013138","journal-title":"Cell"},{"key":"1951_CR91","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1074\/jbc.M509806200","volume":"281","author":"JR McGuire","year":"2006","unstructured":"McGuire JR, Rong J, Li SH, Li XJ (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem 281:3552\u20133559","journal-title":"J Biol Chem"},{"key":"1951_CR92","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/emboj.2012.65","volume":"31","author":"V Costa","year":"2012","unstructured":"Costa V, Scorrano L (2012) Shaping the role of mitochondria in the pathogenesis of Huntington\u2019s disease. EMBO J 31:1853\u20131864","journal-title":"EMBO J"},{"key":"1951_CR93","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuron.2005.06.005","volume":"47","author":"BI Bae","year":"2005","unstructured":"Bae BI, Xu H, Igarashi S et al (2005) p53 mediates cellular dysfunction and behavioral abnormalities in Huntington\u2019s disease. Neuron 47:29\u201341","journal-title":"Neuron"},{"key":"1951_CR94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","volume":"17","author":"MM Zeron","year":"2001","unstructured":"Zeron MM, Chen N, Moshaver A et al (2001) Mutant Huntingtin enhances excitotoxic cell death. Mol Cell Neurosci 17:41\u201353","journal-title":"Mol Cell Neurosci"},{"key":"1951_CR95","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/sj.emboj.7600426","volume":"23","author":"CI Holmberg","year":"2004","unstructured":"Holmberg CI, Staniszewski KE, Mensah KN, Matouschek A, Morimoto RI (2004) Inefficient degradation of truncated polyglutamine proteins by the proteasome. EMBO J 23:4307\u20134318","journal-title":"EMBO J"},{"key":"1951_CR96","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"1951_CR97","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-62703-438-8_3","volume":"1017","author":"W Song","year":"2013","unstructured":"Song W, Smith MR, Syed A (2013) Morphometric analysis of Huntington\u2019s disease neurodegeneration in Drosophila. Methods Mol Biol 1017:41\u201357","journal-title":"Methods Mol Biol"},{"key":"1951_CR98","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.6039-08.2009","volume":"29","author":"H Diekmann","year":"2009","unstructured":"Diekmann H, Anichtchik O, Fleming A et al (2009) Decreased BDNF levels are a major contributor to the embryonic phenotype of Huntingtin knockdown zebrafish. J Neurosci 29:1343\u20131349","journal-title":"J Neurosci"},{"key":"1951_CR99","doi-asserted-by":"crossref","unstructured":"Mason RP, Casu M, Butler N (2013) Gutathione peroxidase activity is neuroprotective in models of Huntington\u2019s disease. Nat Genet\u00a045:1249\u20131254","DOI":"10.1038\/ng.2732"},{"key":"1951_CR100","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP (1997) Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nat Genet 15:197\u2013200","journal-title":"Nat Genet"},{"key":"1951_CR101","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","volume":"8","author":"K Acevedo-Torres","year":"2009","unstructured":"Acevedo-Torres K, Berr\u00edos L, Rosario N et al (2009) Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington\u2019s disease. DNA Repair (Amst) 8:126\u2013136","journal-title":"DNA Repair (Amst)"},{"key":"1951_CR102","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1046\/j.1471-4159.2001.00689.x","volume":"79","author":"MB Bogdanov","year":"2001","unstructured":"Bogdanov MB, Andreassen OA, Dedeoglu A, Ferrante RJ, Beal MF (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington\u2019s disease. J Neurochem 79:1246\u20131249","journal-title":"J Neurochem"},{"key":"1951_CR103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1385\/NMM:1:3:183","volume":"1","author":"T Kiechle","year":"2002","unstructured":"Kiechle T, Dedeoglu A, Kubilus J (2002) Cytochrome\u00a0c and caspase-9 expression in Huntington\u2019s disease. Neuromolecular Med 1:183\u2013195","journal-title":"Neuromolecular Med"},{"key":"1951_CR104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/hmg\/ddi423","volume":"15","author":"JS Bett","year":"2006","unstructured":"Bett JS, Goellner GM, Woodman B, Pratt G, Rechsteiner M, Bates GP (2006) Proteasome impairment does not contribute to pathogenesis in R6\/2 Huntington\u2019s disease mice: exclusion of proteasome activator REG gamma as a therapeutic target. Hum Mol Genet 15:33\u201344","journal-title":"Hum Mol Genet"},{"key":"1951_CR105","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1093\/hmg\/ddn211","volume":"17","author":"H Seo","year":"2008","unstructured":"Seo H, Kim W, Isacson O (2008) Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II\/III in YAC72 and R6\/2 transgenic mice partially model Huntington\u2019s disease patients. Hum Mol Genet 17:3144\u20133153","journal-title":"Hum Mol Genet"},{"key":"1951_CR106","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","volume":"8","author":"G Schilling","year":"1999","unstructured":"Schilling G, Becher MW, Sharp AH (1999) Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of Huntingtin. Hum Mol Genet 8:397\u2013407","journal-title":"Hum Mol Genet"},{"key":"1951_CR107","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","volume":"263","author":"EG McGeer","year":"1976","unstructured":"McGeer EG, McGeer PL (1976) Duplication of biochemical changes of Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids. Nature 263:517\u2013519","journal-title":"Nature"},{"key":"1951_CR108","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","volume":"263","author":"JT Coyle","year":"1976","unstructured":"Coyle JT, Schwarcz R (1976) Lesion of striatal neurones with kainic acid provides a model for Huntington\u2019s chorea. Nature 263:244\u2013246","journal-title":"Nature"},{"key":"1951_CR109","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","volume":"90","author":"R Schwarcz","year":"2010","unstructured":"Schwarcz R, Guidetti P, Sathyasaikumar KV, Muchowski PJ (2010) Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington\u2019s disease. Prog Neurobiol 90:230\u2013245","journal-title":"Prog Neurobiol"},{"key":"1951_CR110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","volume":"321","author":"MF Beal","year":"1986","unstructured":"Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB (1986) Replication of the neurochemical characteristics of Huntington\u2019s disease by quinolinic acid. Nature 321:168\u2013171","journal-title":"Nature"},{"key":"1951_CR111","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1523\/JNEUROSCI.08-10-03901.1988","volume":"8","author":"MF Beal","year":"1988","unstructured":"Beal MF, Kowall NW, Swartz KJ, Ferrante RJ, Martin JB (1988) Systemic approaches to modifying quinolinic acid striatal lesions in rats. J Neurosci 8:3901\u20133908","journal-title":"J Neurosci"},{"key":"1951_CR112","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/exnr.1993.1006","volume":"119","author":"RJ Ferrante","year":"1993","unstructured":"Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF (1993) Excitotoxin lesions in primates as a model for Huntington\u2019s disease: histopathologic and neurochemicalcharacterization. Exp Neurol 119:46\u201371","journal-title":"Exp Neurol"},{"key":"1951_CR113","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1476-5381.2012.01994.x","volume":"168","author":"ME Solesio","year":"2013","unstructured":"Solesio ME, Saez-Atienzar S, Jordan J, Galindo MF (2013) 3-Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activating the mitochondrial fission pathway. Br J Pharmacol 168:63\u201375","journal-title":"Br J Pharmacol"},{"key":"1951_CR114","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1749-6632.2003.tb07541.x","volume":"993","author":"SO Bachurin","year":"2003","unstructured":"Bachurin SO, Shevtsova EP, Kireeva EG, Oxenkrug GF, Sablin SO (2003) Mitochondria as a target for neurotoxins and neuroprotective agents. Ann N Y Acad Sci 993:334\u2013349","journal-title":"Ann N Y Acad Sci"},{"key":"1951_CR115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(08)61074-0","volume":"372","author":"RS Doody","year":"2008","unstructured":"Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer\u2019s disease: a randomised, double-blind, placebo-controlled study. Lancet 372:207\u2013215","journal-title":"Lancet"},{"key":"1951_CR116","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-3-15","volume":"3","author":"J Wu","year":"2008","unstructured":"Wu J, Li Q, Bezprozvanny I (2008) Evaluation of Dimebon in cellular model of Huntington\u2019s disease. Mol Neurodegener 3:15","journal-title":"Mol Neurodegener"},{"key":"1951_CR117","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1358\/dnp.2010.23.8.1500435","volume":"23","author":"I Bezprozvanny","year":"2010","unstructured":"Bezprozvanny I (2010) The rise and fall of Dimebon. Drug News Perspect 23:518\u2013523","journal-title":"Drug News Perspect"},{"key":"1951_CR118","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1034\/j.1600-079X.2000.290108.x","volume":"29","author":"W Qi","year":"2000","unstructured":"Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW, Garcia JJ (2000) Increased levels of oxidatively damaged DNA induced by chromium(III) and H2O2: protection by melatonin and related molecules. J Pineal Res 29:54\u201361","journal-title":"J Pineal Res"},{"key":"1951_CR119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1385\/CBB:34:2:237","volume":"34","author":"RJ Reiter","year":"2001","unstructured":"Reiter RJ, Tan DX, Manchester LC, Qi W (2001) Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 34:237\u2013256","journal-title":"Cell Biochem Biophys"},{"key":"1951_CR120","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1096\/fj.03-1031fje","volume":"18","author":"SA Andrabi","year":"2004","unstructured":"Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF (2004) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 18:869\u2013871","journal-title":"FASEB J"},{"key":"1951_CR121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-079X.1993.tb00511.x","volume":"15","author":"A Menendez-pelaez","year":"1993","unstructured":"Menendez-pelaez A, Reiter RJ (1993) Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 15:59\u201369","journal-title":"J Pineal Res"},{"key":"1951_CR122","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1600-079X.2006.00335.x","volume":"41","author":"B Chetsawang","year":"2006","unstructured":"Chetsawang B, Putthaprasart C, Phansuwan-Pujito P, Govitrapong P (2006) Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2. J Pineal Res 41:116\u2013123","journal-title":"J Pineal Res"},{"key":"1951_CR123","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-079X.2009.00680.x","volume":"46","author":"W Wisessmith","year":"2009","unstructured":"Wisessmith W, Phansuwan-Pujito P, Govitrapong P, Chetsawang B (2009) Melatonin reduces induction of Bax, caspase and cell death in methamphetamine-treated human neuroblastoma SH-SY5Y cultured cells. J Pineal Res 46:433\u2013440","journal-title":"J Pineal Res"},{"key":"1951_CR124","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/appi.neuropsych.21.2.226","volume":"21","author":"J Alders","year":"2009","unstructured":"Alders J, Smits M, Kremer B, Naarding P (2009) The role of melatonin in sleep disturbances in end-stage Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci 21:226\u2013227","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1951_CR125","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","volume":"256","author":"NA Aziz","year":"2009","unstructured":"Aziz NA, Pijl H, Fr\u00f6lich M et al (2009) Delayed onset of the diurnal melatonin rise in patients with Huntington\u2019s disease. J Neurol 256:1961\u20131965","journal-title":"J Neurol"},{"key":"1951_CR126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","volume":"25","author":"AJ Morton","year":"2005","unstructured":"Morton AJ, Wood NI, Hastings MH (2005) Disintegration of the sleep-wake cycle and circadian timing in Huntington\u2019s disease. J Neurosci 25:157\u2013163","journal-title":"J Neurosci"},{"key":"1951_CR127","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2005.03.053","volume":"1046","author":"E Nam","year":"2005","unstructured":"Nam E, Lee SM, Koh SE, Joo WS, Maeng S, Im HI, Kim YS (2005) Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 1046:90\u201396","journal-title":"Brain Res"},{"key":"1951_CR128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","volume":"37","author":"I T\u00fanez","year":"2004","unstructured":"T\u00fanez I, Montilla P, Del Carmen Mu\u00f1oz M, Feij\u00f3o M, Salcedo M (2004) Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington\u2019s disease. J Pineal Res 37:252\u2013256","journal-title":"J Pineal Res"},{"key":"1951_CR129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF03180581","volume":"65","author":"I Tasset","year":"2009","unstructured":"Tasset I, Esp\u00ednola C, Medina FJ (2009) Neuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma. J Physiol Biochem 65:291\u2013296","journal-title":"J Physiol Biochem"},{"key":"1951_CR130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-079X.2009.00721.x","volume":"48","author":"MJ Jou","year":"2010","unstructured":"Jou MJ, Peng TI, Hsu LF (2010) Visualization of melatonin\u2019s multiple mitochondrial levels of protection against mitochondrial Ca2+ mediated permeability transition and beyond in rat brain astrocytes. J Pineal Res 48:20\u201338","journal-title":"J Pineal Res"},{"key":"1951_CR131","doi-asserted-by":"crossref","first-page":"14496","DOI":"10.1523\/JNEUROSCI.3059-11.2011","volume":"31","author":"X Wang","year":"2011","unstructured":"Wang X, Sirianni A, Pei Z (2011) The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity. J Neurosci 31:14496\u201314507","journal-title":"J Neurosci"},{"key":"1951_CR132","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","volume":"22","author":"RJ Ferrante","year":"2002","unstructured":"Ferrante RJ, Andreassen OA, Dedeoglu A, Ferrante KL, Jenkins BG, Hersch SM, Beal MF (2002) Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington\u2019s disease. J Neurosci 22:1592\u20131599","journal-title":"J Neurosci"},{"key":"1951_CR133","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.bbadis.2006.03.004","volume":"1762","author":"KM Smith","year":"2006","unstructured":"Smith KM, Matson S, Matson WR (2006) Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington\u2019s disease mice. Biochim Biophys Acta 1762:616\u2013626","journal-title":"Biochim Biophys Acta"},{"key":"1951_CR134","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0891-5849(95)02227-9","volume":"20","author":"CA Rice-Evans","year":"1996","unstructured":"Rice-Evans CA, Miller NJ, Paganga G (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933\u2013956","journal-title":"Free Radic Biol Med"},{"key":"1951_CR135","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2013.01.032","volume":"236","author":"SS Karuppagounder","year":"2013","unstructured":"Karuppagounder SS, Madathil SK, Pandey M, Haobam R, Rajamma U, Mohanakumar KP (2013) Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson\u2019s disease in rats. Neuroscience 236:136\u2013148","journal-title":"Neuroscience"},{"key":"1951_CR136","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1093\/jn\/135.7.1718","volume":"135","author":"VC Boer","year":"2005","unstructured":"Boer VC, Dihal AA, van der Woude H (2005) Tissue distribution of quercetin in rats and pigs. J Nutr 135:1718\u20131725","journal-title":"J Nutr"},{"key":"1951_CR137","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbadis.2012.11.018","volume":"1832","author":"R Sandhir","year":"2013","unstructured":"Sandhir R, Mehrotra A (2013) Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington\u2019s disease. Biochim Biophys Acta 1832:421\u2013430","journal-title":"Biochim Biophys Acta"},{"key":"1951_CR138","author":"J Chakraborty","year":"2013","unstructured":"Chakraborty J, Singh R, Dutta D, Naskar A, Usha R, Mohanakumar KP (2013) Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. CNS Neurosci Ther 20:10\u20139. doi: 10.1111\/cns.12189","journal-title":"CNS Neurosci Ther"},{"key":"1951_CR139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000334273","volume":"9","author":"R Sandhir","year":"2012","unstructured":"Sandhir R, Sood A, Mehrotra A, Kamboj SS (2012) N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington\u2019s disease. Neurodegener Dis 9:145\u2013157","journal-title":"Neurodegener Dis"},{"key":"1951_CR140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0006-8993(99)01819-3","volume":"842","author":"M Banaclocha","year":"1999","unstructured":"Banaclocha M, Mart\u00ednez N (1999) N-acetylcysteine elicited increase in cytochrome\u00a0c oxidase activity in mice synaptic mitochondria. Brain Res 842:249\u2013251","journal-title":"Brain Res"},{"key":"1951_CR141","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(00)02005-9","volume":"859","author":"M Banaclocha","year":"2000","unstructured":"Banaclocha M (2000) N-acetylcysteine elicited increase in complex I activity in synaptic mitochondria from aged mice: implications for treatment of Parkinson\u2019s disease. Brain Res 859:173\u2013175","journal-title":"Brain Res"},{"key":"1951_CR142","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/hum.2009.023","volume":"20","author":"PM Keeney","year":"2009","unstructured":"Keeney PM, Quigley CK, Dunham LD (2009) Mitochondrial gene therapy augments mitochondrial physiology in a Parkinson\u2019s disease cell model. Hum Gene Ther 20:897\u2013907","journal-title":"Hum Gene Ther"},{"key":"1951_CR143","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","volume":"12","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Dedeoglu A, Beal MF (2001) Lipoic acid improves survival in transgenic mouse models of Huntington\u2019s disease. Neuroreport 12:3371\u20133373","journal-title":"Neuroreport"},{"key":"1951_CR144","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2202-5-17","volume":"5","author":"JM Gil","year":"2004","unstructured":"Gil JM, Leist M, Popovic N, Brundin P, Peters\u00e9n A (2004) Asialoerythropoietin is not effective in the R6\/2 line of Huntington\u2019s disease mice. BMC Neurosci 5:17","journal-title":"BMC Neurosci"},{"key":"1951_CR145","doi-asserted-by":"crossref","first-page":"11840","DOI":"10.1073\/pnas.0502177102","volume":"102","author":"T Nguyen","year":"2005","unstructured":"Nguyen T, Hamby A, Massa SM (2005) Clioquinol down-regulates mutant Huntingtin expression in vitro and mitigates pathology in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci USA 102:11840\u201311845","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR146","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/ana.20075","volume":"55","author":"W Duan","year":"2004","unstructured":"Duan W, Guo Z, Jiang H, Ladenheim B, Xu X, Cadet JL, Mattson MP (2004) Paroxetine retards disease onset and progression in Huntingtin mutant mice. Ann Neurol 55:590\u2013594","journal-title":"Ann Neurol"},{"key":"1951_CR147","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","volume":"280","author":"G Gardian","year":"2005","unstructured":"Gardian G, Browne SE, Choi DK (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease. J Biol Chem 280:556\u2013563","journal-title":"J Biol Chem"},{"key":"1951_CR148","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mds.870110310","volume":"11","author":"K Kieburtz","year":"1996","unstructured":"Kieburtz K, Feigin A, McDermott M (1996) A controlled trial of remacemide hydrochloride in Huntington\u2019s disease. Mov Disord 11:273\u2013277","journal-title":"Mov Disord"},{"key":"1951_CR149","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/WNL.57.3.397","volume":"57","author":"Huntington Study Group","year":"2001","unstructured":"Huntington Study Group (2001) A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington\u2019s disease. Neurology 57:397\u2013404","journal-title":"Neurology"},{"key":"1951_CR150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12264-009-0513-3","volume":"25","author":"H Kalonia","year":"2009","unstructured":"Kalonia H, Kumar P, Kumar A, Nehru B (2009) Effects of caffeic acid, rofecoxib, and their combination against quinolinic acid-induced behavioral alterations and disruption in glutathione redox status. Neurosci Bull 25:343\u2013352","journal-title":"Neurosci Bull"},{"key":"1951_CR151","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2004.07.011","volume":"17","author":"F Norflus","year":"2004","unstructured":"Norflus F, Nanje A, Gutekunst CA (2004) Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington\u2019s disease transgenic mice. Neurobiol Dis 17:319\u2013325","journal-title":"Neurobiol Dis"},{"key":"1951_CR152","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.brainres.2006.08.035","volume":"1118","author":"ST Lee","year":"2006","unstructured":"Lee ST, Chu K, Park JE, Kang L, Ko SY, Jung KH, Kim M (2006) Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington\u2019s disease. Brain Res 1118:199\u2013207","journal-title":"Brain Res"},{"key":"1951_CR153","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1212\/WNL.59.5.694","volume":"59","author":"L VerhagenMetman","year":"2002","unstructured":"VerhagenMetman L, Morris MJ, Farmer C, Gillespie M, Mosby K, Wuu J, Chase TN (2002) Huntington\u2019s disease: a randomized, controlled trial using the NMDA-antagonist amantadine. Neurology 59:694\u2013699","journal-title":"Neurology"},{"key":"1951_CR154","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s100720200081","volume":"2","author":"C Lucetti","year":"2002","unstructured":"Lucetti C, Gambaccini G, Bernardini S, Dell\u2019Agnello G, Petrozzi L, Rossi G, Bonuccelli U (2002) Amantadine in Huntington\u2019s disease: open-label video-blinded study. Neurol Sci 2:S83\u2013S84","journal-title":"Neurol Sci"},{"key":"1951_CR155","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/01.WNL.0000068165.07883.64","volume":"60","author":"C Lucetti","year":"2003","unstructured":"Lucetti C, Del Dotto P, Gambaccini G (2003) IV amantadine improves chorea in Huntington\u2019s disease: an acute randomized, controlled study. Neurology 60:1995\u20131997","journal-title":"Neurology"},{"key":"1951_CR156","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneur.60.7.996","volume":"60","author":"P O\u2019Suilleabhain","year":"2003","unstructured":"O\u2019Suilleabhain P, Dewey RB Jr (2003) A randomized trial of amantadine in Huntington disease. Arch Neurol 60:996\u2013998","journal-title":"Arch Neurol"},{"key":"1951_CR157","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","volume":"68","author":"A Beister","year":"2004","unstructured":"Beister A, Kraus P, Kuhn W, Dose M, Weindl A, Gerlach M (2004) The N-methyl-d-aspartate antagonist memantine retards progression of Huntington\u2019s disease. J Neural Transm Suppl 68:117\u2013122","journal-title":"J Neural Transm Suppl"},{"key":"1951_CR158","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bcp.2007.10.019","volume":"75","author":"J McAllister","year":"2008","unstructured":"McAllister J, Ghosh S, Berry D, Park M, Sadeghi S, Wang KX, Parker WD, Swerdlow RH (2008) Effects of memantine on mitochondrial function. Biochem Pharmacol 75:956\u2013964","journal-title":"Biochem Pharmacol"},{"key":"1951_CR159","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1167\/iovs.08-2499","volume":"50","author":"WK Ju","year":"2009","unstructured":"Ju WK, Kim KY, Angert M, Duong-Polk KX, Lindsey JD, Ellisman MH, Weinreb RN (2009) Memantine blocks mitochondrial OPA1 and cytochrome\u00a0c release and subsequent apoptotic cell death in glaucomatous retina. Invest Ophthalmol Vis Sci 50:707\u2013716","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1951_CR160","doi-asserted-by":"crossref","first-page":"29228","DOI":"10.1074\/jbc.M602629200","volume":"281","author":"P Dikshit","year":"2006","unstructured":"Dikshit P, Chatterjee M, Goswami A, Mishra A, Jana NR (2006) Aspirin induces apoptosis through the inhibition of proteasome function. J Biol Chem 281:29228\u201329235","journal-title":"J Biol Chem"},{"key":"1951_CR161","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1046\/j.1471-4159.2003.01706.x","volume":"85","author":"A Dedeoglu","year":"2003","unstructured":"Dedeoglu A, Kubilus JK, Yang L, Ferrante KL, Hersch SM, Beal MF, Ferrante RJ (2003) Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington\u2019s disease transgenic mice. J Neurochem 85:1359\u20131367","journal-title":"J Neurochem"},{"key":"1951_CR162","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","volume":"11","author":"DA Shear","year":"2000","unstructured":"Shear DA, Haik KL, Dunbar GL (2000) Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 11:1833\u20131837","journal-title":"Neuroreport"},{"key":"1951_CR163","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1212\/01.WNL.0000090629.40891.4B","volume":"61","author":"P Verbessem","year":"2003","unstructured":"Verbessem P, Lemiere J, Eijnde BO et al (2003) Creatine supplementation in Huntington\u2019s disease: a placebo-controlled pilot trial. Neurology 61:925\u2013930","journal-title":"Neurology"},{"key":"1951_CR164","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","volume":"66","author":"SM Hersch","year":"2006","unstructured":"Hersch SM, Gevorkian S, Marder K et al (2006) Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2\u2032dG. Neurology 66:250\u2013252","journal-title":"Neurology"},{"key":"1951_CR165","doi-asserted-by":"crossref","first-page":"H506","DOI":"10.1152\/ajpheart.00919.2012","volume":"305","author":"J Branovets","year":"2013","unstructured":"Branovets J, Sepp M, Kotlyarova S et al (2013) Unchanged mitochondrial organization and compartmentation of high-energy phosphates in creatine-deficient GAMT\u2212\/\u2212 mouse hearts. Am J Physiol Heart Circ Physiol 305:H506\u2013H520","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1951_CR166","doi-asserted-by":"crossref","unstructured":"Ribeiro M, Silva AC, Rodrigues J, Naia L, Rego AC (2013) Oxidizing effects of exogenous stressors in Huntington\u2019s disease knock-in striatal cells: protective effect of cystamine and creatine. Toxicol Sci 136:487\u2013499","DOI":"10.1093\/toxsci\/kft199"},{"key":"1951_CR167","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","volume":"50","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Huang HM et al (2001) Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington\u2019s disease. Ann Neurol 50:112\u2013117","journal-title":"Ann Neurol"},{"key":"1951_CR168","doi-asserted-by":"crossref","first-page":"e34776","DOI":"10.1371\/journal.pone.0034776","volume":"7","author":"E Miquel","year":"2013","unstructured":"Miquel E, Cassina A, Mart\u00ednez-Palma L et al (2013) Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS One 7:e34776","journal-title":"PLoS One"},{"key":"1951_CR169","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00210-004-0959-9","volume":"370","author":"B Zucker","year":"2004","unstructured":"Zucker B, Ludin DE, Gerds TA, L\u00fccking CH, Landwehrmeyer GB, Feuerstein TJ (2004) Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington\u2019s disease. Naunyn Schmiedebergs Arch Pharmacol 370:131\u2013139","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1951_CR170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00417-004-0872-4","volume":"242","author":"A Pielen","year":"2004","unstructured":"Pielen A, Kirsch M, Hofmann HD, Feuerstein TJ, Lagr\u00e8ze WA (2004) Retinal ganglion cell survival is enhanced by gabapentin-lactam in vitro: evidence for involvement of mitochondrial KATP channels. Graefes Arch Clin Exp Ophthalmol 242:240\u2013244","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1951_CR171","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2006.08.036","volume":"407","author":"J Wu","year":"2006","unstructured":"Wu J, Tang T, Bezprozvanny I (2006) Evaluation of clinically relevant glutamate pathway inhibitors in in vitro model of Huntington\u2019s disease. Neurosci Lett 407:219\u2013223","journal-title":"Neurosci Lett"},{"key":"1951_CR172","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2011.11.030","volume":"674","author":"P Kumar","year":"2012","unstructured":"Kumar P, Kalonia H, Kumar A (2012) Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity. Eur J Pharmacol 674:265\u2013274","journal-title":"Eur J Pharmacol"},{"key":"1951_CR173","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0304-3940(95)12137-S","volume":"201","author":"V Mary","year":"1995","unstructured":"Mary V, Wahl F, Stutzmann JM (1995) Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of glutamatergic neurotransmission. Neurosci Lett 201:92\u201396","journal-title":"Neurosci Lett"},{"key":"1951_CR174","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1212\/WNL.53.5.1000","volume":"53","author":"B Kremer","year":"1999","unstructured":"Kremer B, Clark CM, Almqvist EW et al (1999) Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology 53:1000\u20131011","journal-title":"Neurology"},{"key":"1951_CR175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.brainresbull.2006.12.006","volume":"71","author":"YJ Kim","year":"2007","unstructured":"Kim YJ, Ko HH, Han ES, Lee CS (2007) Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death. Brain Res Bull 71:633\u2013640","journal-title":"Brain Res Bull"},{"key":"1951_CR176","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.wnf.0000186648.93612.a5","volume":"28","author":"M Tommaso de","year":"2005","unstructured":"de Tommaso M, Di Fruscolo O, Sciruicchio V et al (2005) Efficacy of levetiracetam in Huntington disease. Clin Neuropharmacol 28:280\u2013284","journal-title":"Clin Neuropharmacol"},{"key":"1951_CR177","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1528-1167.2006.00454.x","volume":"47","author":"JE Gibbs","year":"2006","unstructured":"Gibbs JE, Walker MC, Cock HR (2006) Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus. Epilepsia 47:469\u2013478","journal-title":"Epilepsia"},{"key":"1951_CR178","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0361-9230(03)00141-2","volume":"61","author":"NI Wood","year":"2003","unstructured":"Wood NI, Morton AJ (2003) Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington\u2019s disease mutation. Brain Res Bull 61:375\u2013383","journal-title":"Brain Res Bull"},{"key":"1951_CR179","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuropharm.2008.09.012","volume":"56","author":"N Crespo-Biel","year":"2009","unstructured":"Crespo-Biel N, Camins A, Pall\u00e0s M, Canudas AM (2009) Evidence of calpain\/cdk5 pathway inhibition by lithium in 3-nitropropionic acid toxicity in vivo and in vitro. Neuropharmacology 56:422\u2013428","journal-title":"Neuropharmacology"},{"key":"1951_CR180","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0447.1977.tb03561.x","volume":"56","author":"P Vestergaard","year":"1977","unstructured":"Vestergaard P, Baastrup PC, Petersson H (1977) Lithium treatment of Huntington\u2019s chorea. A placebo-controlled clinical trial. Acta Psychiatr Scand 56:183\u2013188","journal-title":"Acta Psychiatr Scand"},{"key":"1951_CR181","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0019-5545.105522","volume":"55","author":"V Danivas","year":"2013","unstructured":"Danivas V, Moily NS, Thimmaiah R, Muralidharan K, Purushotham M, Muthane U, Jain S (2013) Off label use of lithium in the treatment of Huntington\u2019s disease: a case series. Indian J Psychiatry 55:81\u201383","journal-title":"Indian J Psychiatry"},{"key":"1951_CR182","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0887-2333(01)00037-6","volume":"15","author":"G Repetto","year":"2001","unstructured":"Repetto G, del Peso A, Sanz P, Repetto M (2001) In vitro effects of lithium and nickel at different levels on Neuro-2a mouse neuroblastoma cells. Toxicol In Vitro 15:363\u2013368","journal-title":"Toxicol In Vitro"},{"key":"1951_CR183","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/80538","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797\u2013801","journal-title":"Nat Med"},{"key":"1951_CR184","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1111\/j.0953-816X.2004.03372.x","volume":"19","author":"E Diguet","year":"2004","unstructured":"Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F (2004) Deleterious effects of minocycline in animal models of Parkinson\u2019s disease and Huntington\u2019s disease. Eur J Neurosci 19:3266\u20133276","journal-title":"Eur J Neurosci"},{"key":"1951_CR185","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.nbd.2004.09.017","volume":"18","author":"K Bantubungi","year":"2005","unstructured":"Bantubungi K, Jacquard C, Greco A et al (2005) Minocycline in phenotypic models of Huntington\u2019s disease. Neurobiol Dis 18:206\u2013217","journal-title":"Neurobiol Dis"},{"key":"1951_CR186","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00004850-200411000-00004","volume":"19","author":"RM Bonelli","year":"2004","unstructured":"Bonelli RM, H\u00f6dl AK, Hofmann P, Kapfhammer HP (2004) Neuroprotection in Huntington\u2019s disease: a 2-year study on minocycline. Int Clin Psychopharmacol 19:337\u2013342","journal-title":"Int Clin Psychopharmacol"},{"key":"1951_CR187","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bcp.2008.11.003","volume":"77","author":"A Gieseler","year":"2009","unstructured":"Gieseler A, Schultze AT, Kupsch K, Haroon MF, Wolf G, Siemen D, Kreutzmann P (2009) Inhibitory modulation of the mitochondrial permeability transition by minocycline. Biochem Pharmacol 77:888\u2013896","journal-title":"Biochem Pharmacol"},{"key":"1951_CR188","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1742-4658.2009.06904.x","volume":"276","author":"K Kupsch","year":"2009","unstructured":"Kupsch K, Hertel S, Kreutzmann P, Wolf G, Wallesch CW, Siemen D, Sch\u00f6nfeld P (2009) Impairment of mitochondrial function by minocycline. FEBS J 276:1729\u20131738","journal-title":"FEBS J"},{"key":"1951_CR189","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","volume":"36","author":"B Ravikumar","year":"2004","unstructured":"Ravikumar B, Vacher C, Berger Z (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36:585\u2013595","journal-title":"Nat Genet"},{"key":"1951_CR190","first-page":"114","volume":"1","author":"SS Deepa","year":"2013","unstructured":"Deepa SS, Walsh ME, Hamilton RT (2013) Rapamycin modulates markers of mitochondrial biogenesis and fatty acid oxidation in the adipose tissue of db\/db mice. J Biochem Pharmacol Res 1:114\u2013123","journal-title":"J Biochem Pharmacol Res"},{"key":"1951_CR191","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1073\/pnas.261709098","volume":"99","author":"J Liu","year":"2002","unstructured":"Liu J, Killilea DW, Ames BN (2002) Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-l-carnitine and\/or R-alpha-lipoic acid. Proc Natl Acad Sci USA 99:1876\u20131881","journal-title":"Proc Natl Acad Sci USA"},{"key":"1951_CR192","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm985","volume":"10","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Machida Y, Niu S, Ikeda T, Jana NR, Doi H, Kurosawa M, Nekooki M, Nukina N (2004) Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease. Nat Med 10:148\u2013154","journal-title":"Nat Med"},{"key":"1951_CR193","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/sj.cdd.4402035","volume":"14","author":"R Yamaguchi","year":"2007","unstructured":"Yamaguchi R, Andreyev A, Murphy AN, Perkins GA, Ellisman MH, Newmeyer DD (2007) Mitochondria frozen with trehalose retain a number of biological functions and preserve outer membrane integrity. Cell Death Differ 14:616\u2013624","journal-title":"Cell Death Differ"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-013-1951-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-013-1951-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T05:56:04Z","timestamp":1716357364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-013-1951-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,29]]},"references-count":193,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s11010-013-1951-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,29]]}}}